Nihon Toseki Igakkai Zasshi
Online ISSN : 1883-082X
Print ISSN : 1340-3451
ISSN-L : 1340-3451
An overview of dialysis treatment in Japan (as of Dec. 31, 2005)
[in Japanese][in Japanese][in Japanese][in Japanese][in Japanese][in Japanese][in Japanese][in Japanese][in Japanese][in Japanese][in Japanese][in Japanese][in Japanese][in Japanese][in Japanese][in Japanese][in Japanese][in Japanese][in Japanese][in Japanese][in Japanese][in Japanese][in Japanese]
Author information
JOURNAL FREE ACCESS

2007 Volume 40 Issue 1 Pages 1-30

Details
Abstract

A statistical survey conducted at the end of 2005 covered 3,985 medical facilities across Japan, and 3,940 facilities (98.87%) responded. The dialysis population in Japan at the end of 2005 was 257,765, which showed an increase of 9,599 patients (3.87%) from the end of the previous year. The number of patients per million was 2,017.6. The crude death rate for one year (from the end of 2004 to the end of 2005) was 9.5%. The mean age of the patients who began dialysis (in 2005) was 66.2, and the mean age of the entire dialysis population was 63.9. The primary diseases of the patients who began dialysis were diabetic renal disease (42.0%) and chronic glomerulonephritis (27.3%). The mean (±S.D.) serum ferritin concentration of all the dialysis patients was 191 (±329) ng/mL. The percentages of antihypertensive agents administered to the hemodialysis patients were as follows: calcium antagonist, 50.3%; angiotension-converting enzyme inhibitor, 11.5%; and angiotensin II-receptor antagonist, 33.9%. Of the peritoneal dialysis patients, 33.4% used automatic peritoneal perfusion devices. Moreover, 7.3% of the peritoneal dialysis patients received dialysis treatment only in the daytime, and 15% received the treatment only at night. Icodextrin solution was used by 37.2% of the peritoneal dialysis patients. The average amount of dialysis solution used by the peritoneal dialysis patients was 7.43 (±2.52) L/day and the average amount of the removal fluid was 0.81 (±0.60) L/day. A peritoneal equilibration test was conducted on 67% of the patients, and the mean dialysate to plasma (D/P) ratio was 0.65 (±0.13). The annual incidence of peritonitis in the peritoneal dialysis patients was 19.7%. Of the 126,040 patients who responded to the inquiry of the therapeutic situation of peritoneal dialysis, 676 (0.7%) had a history of encapsulated peritoneal sclerosis and 66 (0.1%) were treated for encapsulated peritoneal sclerosis. The mean life expectancy of the dialysis population in 2003 was calculated according to sex and age. Results showed that the mean life expectancy of the dialysis population was approximately 40-60% of that of the general population of the same sex and age.

Content from these authors
© 2007 The Japanese Society for Dialysis Therapy
Next article
feedback
Top